Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population

Journal of Hypertension

Volumn 18, Issue 8, 2000, Pages 1121-1128

  Luchner, Andreas ^a   Burnett Jr , John C ^b   Jougasaki, Michihisa ^b   Hense, Hans Werner ^c,d   Heid, Iris M ^a   Muders, Frank ^a   Riegger, Gänter A J ^a   Schunkert, Heribert ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b MAYO CLINIC   (United States)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Heart failure; Hypertension; LV dysfunction; LV hypertrophy; Natriuretic peptides

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033864121     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018080-00018     Document Type: Article

References (28)

1. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide
2. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
3. Brain natriuretic peptide predicts mortality in the elderly
4. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohumoral predictors of left ventricular function and prognosis after myocardial infarction
5. Neurohumoral predicition of benefit from carvedilol in ischemic left ventricular dysfunction
6. Biochemical detection of left ventricular systolic dysfunction
7. Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles
8. Distribution of mRNAs for natriuretic peptides in RV hypertrophy after pulmonary arterial banding
9. Differential atrial and ventricular expression of myocardial brain natriuretic peptide during the evolution of heart failure
10. Brain natriuretic peptide as a novel cardiac hormone in humans
11. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
12. Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction
13. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction
14. Rapid ventricular induction of Brain Natriuretic Peptide gene expression in experimental acute myocardial infarction
15. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy
16. Brain Natriuretic Peptide as a marker for hypertensive left ventricular hypertrophy: Changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor
17. Left-ventricular dysfunction
18. Swedish trial in old patients with hypertension (STOP-Hypertension) analyses performed up to 1992
19. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension
20. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
21. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
22. The cardiovascular risk factor profile in the study area Augsburg: Results from the first MONICA survey 1985/85
23. The committee on M-mode standardization of the American Society of Echocardiography: Results on a survey of echocardiographic measurements
24. Methods for detection of left ventricular hypertrophy: Application to hypertensive heart disease
25. Echocardiographic measurements in normal subjects: Evaluation of an adult population without clinically apparent heart disease
26. Determinants of Doppler indexes of left ventricular diastolic function in normal subjects
27. Superiority of brain natriuretic peptide in assessing efficacy of therapy to improve symptoms of congestive heart failure in the outpatient setting
28. Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: Evidence from a population-based study